159 related articles for article (PubMed ID: 9741652)
1. Preferential blockade by clozapine of hyperlocomotion induced by non-competitive NMDA antagonist MK-801.
Ninan I; Kulkarni SK
Indian J Physiol Pharmacol; 1998 Jul; 42(3):375-82. PubMed ID: 9741652
[TBL] [Abstract][Full Text] [Related]
2. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
Gaisler-Salomon I; Weiner I
Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
[TBL] [Abstract][Full Text] [Related]
3. Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats.
Gattaz WF; Schummer B; Behrens S
J Neural Transm Gen Sect; 1994; 96(3):227-32. PubMed ID: 7826573
[TBL] [Abstract][Full Text] [Related]
4. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents.
Millan MJ; Brocco M; Rivet JM; Audinot V; Newman-Tancredi A; Maiofiss L; Queriaux S; Despaux N; Peglion JL; Dekeyne A
J Pharmacol Exp Ther; 2000 Jan; 292(1):54-66. PubMed ID: 10604931
[TBL] [Abstract][Full Text] [Related]
5. Prefrontal cortex lesions cause only minor effects on the hyperlocomotion induced by MK-801 and its reversal by clozapine.
Scorza MC; Meikle MN; Hill XL; Richeri A; Lorenzo D; Artigas F
Int J Neuropsychopharmacol; 2008 Jun; 11(4):519-32. PubMed ID: 18248688
[TBL] [Abstract][Full Text] [Related]
6. Suppressive effect of clozapine but not haloperidol on the increases of neuropeptide-degrading enzymes and glial cells in MK-801-treated rat brain regions.
Arif M; Chikuma T; Ahmed MM; Yoshida S; Kato T
Neurosci Res; 2007 Feb; 57(2):248-58. PubMed ID: 17141345
[TBL] [Abstract][Full Text] [Related]
7. Neuropsychopharmacological profile of remoxipride in comparison with clozapine.
Skuza G; Rogóz Z; Wieczorek A
Pol J Pharmacol; 1997; 49(1):5-15. PubMed ID: 9431546
[TBL] [Abstract][Full Text] [Related]
8. D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats.
Karasawa J; Hashimoto K; Chaki S
Behav Brain Res; 2008 Jan; 186(1):78-83. PubMed ID: 17854919
[TBL] [Abstract][Full Text] [Related]
9. Nicotine and clozapine actions on pre-pulse inhibition deficits caused by N-methyl-D-aspartate (NMDA) glutamatergic receptor blockade.
Levin ED; Petro A; Caldwell DP
Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):581-6. PubMed ID: 15866361
[TBL] [Abstract][Full Text] [Related]
10. Antagonistic activity of ascorbic acid (vitamin C) on dopaminergic modulation: apomorphine-induced stereotypic behavior in mice.
Deshpande C; Dhir A; Kulkarni SK
Pharmacology; 2006; 77(1):38-45. PubMed ID: 16569938
[TBL] [Abstract][Full Text] [Related]
11. Functional alteration by NMDA antagonist: effects of L-Dopa, neuroleptics drug and postnatal administration.
Fredriksson A; Archer T
Amino Acids; 2002; 23(1-3):111-32. PubMed ID: 12373526
[TBL] [Abstract][Full Text] [Related]
12. Effects of 5-hydroxytryptamine2 receptor antagonism on the behavioral activation and immediate early gene expression induced by dizocilpine.
O'Neill MF; Hicks CA; Shaw G; Parameswaran T; Cardwell GP; O'Neill MJ
J Pharmacol Exp Ther; 1998 Dec; 287(3):839-46. PubMed ID: 9864262
[TBL] [Abstract][Full Text] [Related]
13. Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test.
Ishiyama T; Tokuda K; Ishibashi T; Ito A; Toma S; Ohno Y
Eur J Pharmacol; 2007 Oct; 572(2-3):160-70. PubMed ID: 17662268
[TBL] [Abstract][Full Text] [Related]
14. Effect of GNTI, a kappa opioid receptor antagonist, on MK-801-induced hyperlocomotion and stereotypy in mice.
Qi CT; Zou H; Zhang CH; Xie QL; Jin ML; Yu L
Acta Pharmacol Sin; 2006 Nov; 27(11):1401-8. PubMed ID: 17049114
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic drugs prevent the motor hyperactivity induced by psychotomimetic MK-801 in zebrafish (Danio rerio).
Seibt KJ; Oliveira Rda L; Zimmermann FF; Capiotti KM; Bogo MR; Ghisleni G; Bonan CD
Behav Brain Res; 2010 Dec; 214(2):417-22. PubMed ID: 20600350
[TBL] [Abstract][Full Text] [Related]
16. Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats.
Enomoto T; Ishibashi T; Tokuda K; Ishiyama T; Toma S; Ito A
Behav Brain Res; 2008 Jan; 186(2):197-207. PubMed ID: 17881065
[TBL] [Abstract][Full Text] [Related]
17. Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats.
Hoffman DC
J Neural Transm Gen Sect; 1992; 89(1-2):1-10. PubMed ID: 1358122
[TBL] [Abstract][Full Text] [Related]
18. MK-801-induced stereotypy and its antagonism by neuroleptic drugs.
Tiedtke PI; Bischoff C; Schmidt WJ
J Neural Transm Gen Sect; 1990; 81(3):173-82. PubMed ID: 1975747
[TBL] [Abstract][Full Text] [Related]
19. The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating.
Bubeníková V; Votava M; Horácek J; Pálenícek T; Dockery C
Pharmacol Biochem Behav; 2005 Apr; 80(4):591-6. PubMed ID: 15820528
[TBL] [Abstract][Full Text] [Related]
20. Clozapine but not haloperidol suppresses the changes in the levels of neuropeptides in MK-801-treated rat brain regions.
Arif M; Ahmed MM; Kumabe Y; Hoshino H; Chikuma T; Kato T
Neurochem Int; 2006 Aug; 49(3):304-11. PubMed ID: 16567023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]